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April 2, 2013:1461–8missed MIs represent a major cause of legal liability. Similarly, the
advice to interpret an elevated troponin level in the clinical context
is wise, yet may have a limited effect—estimates of pre-test
probability have a high interobserver variability (3). Physicians
often do not make formal quantitative calculations in practice (4)
and make errors when they do (5).
Troponins, as currently used, have an excellent negative predic-
tive value, but poor positive predictive value. The absolute value of
troponin and the degree of increase on sequential testing are
helpful in diagnosing acute MI, but may be less helpful in
confirming thrombotic ACS as the cause. We have observed cases
of acute troponin I increases as great as 10 ng/ml with stroke, diabetic
ketoacidosis, and heart failure. As the key therapeutic decision to
provide antithrombotics or urgent revascularization usually occurs on
presentation, and such therapies can only benefit patients with
significant ACS, practicing clinicians need a second confirmatory test
for ACS. Such a test should be less severely affected by sepsis,
tachyarrhythmia, hypotension, renal failure, chronic coronary disease,
demand ischemia, heart failure, or cardiomyopathy, even if it is
insensitive to small amounts of myonecrosis. That test, arguably, is the
creatine kinase–myocardial band and index.
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Reply
The American College of Cardiology Foundation (ACCF) wel-
comes letters to inform its ongoing work and encourages such
correspondence about its clinical policy statements. Because the
ACCF document development process is rigorous and involves
several layers of review by the writing committee, external peer
reviewers, and participating organizations in the document, it
cannot respond to each issue raised after a document has been
published. The information, however, is forwarded to the Writing
Committee co-chairs and oversight Task Force for review. If any
issues are deemed by the College to affect patient safety, they will
be considered immediately. Otherwise, the information will be
considered during the next revision of the document.
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